The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.
Open accessAbstract
Deficiency of plasma platelet-activating factor (PAF) acetylhydrolase is an autosomal recessive syndrome that has been associated with severe asthma in Japanese children. Acquired deficiency has been described in several human diseases usually associated with severe inflammation. PAF acetylhydrolase catalyzes the degradation of PAF and related phospholipids, which have proinflammatory, allergic, and prothrombotic properties. Thus, a deficiency in the degradation of these lipids should increase the susceptibility to inflammatory and allergic disorders. Miwa et al. reported that PAF acetylhydrolase activity is absent in 4% of the Japanese population, which suggests that it could be a common factor in such disorders, but the molecular basis of the defect is unknown. We show that inherited deficiency of PAF acetylhydrolase is the result of a point mutation in exon 9 and that this mutation completely abolishes enzymatic activity. This mutation is the cause of the lack of enzymatic activity as expression in E. coli of a construct harboring the mutation results in an inactive protein. This mutation as a heterozygous trait is present in 27% in the Japanese population. This finding will allow rapid identification of subjects predisposed to severe asthma and other PAF-mediated disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,533
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719 · cited 1×
“Genomic DNA was isolated by conventional techniques (26) and exon 9 was amplified by the polymerase chain reaction using these genomic DNA samples as templates (27).”
MethodAnalysis of human Y-chromosome-specific reiterated DNA in chromosome variants.
Kunkel, L. M., Smith, K. D., Boyer, S. H., Borgaonkar, D. S., Wachtel, S. S., Miller, O. J., Breg, W. R., Jones, H. W., & Rary, J. M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.3.1245 · Cited by 1,334
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products
Marchuk, D., Drumm, M., Saulino, A., & Collins, F. S. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.5.1154 · Cited by 1,160
Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38167-5 · Cited by 889
Self-citationRespiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart.
Ninan, T. K., & Russell, G. (1992) · BMJ · doi:10.1136/bmj.304.6831.873 · Cited by 682
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforinit, D. M., Dietsch, G., Schimpf, B., Hooper, S., Trong, H. L., Cousens, L. S., Zimmerman, G. A., et al. (1995) · Nature · doi:10.1038/374549a0 · Cited by 526
Self-citationAbsence of Thrombosis in Subjects with Heterozygous Protein C Deficiency
Miletich, J., Sherman, L., & Broze, G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710153171604 · Cited by 524
Cited by
Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757
Platelet-Activating Factor and Related Lipid Mediators
Prescott, S. M., Zimmerman, G. A., Stafforini, D. M., & McIntyre, T. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.419 · Cited by 748
Self-citationInflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Recent progress in phospholipase A2 research: From cells to animals to humans
Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., & Yamamoto, K. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.12.001 · Cited by 507
Zalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
Ishii, S., & Shimizu, T. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(99)00016-8 · Cited by 384
Zimmerman, G. A., McIntyre, T. M., Prescott, S. M., & Stafforini, D. M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00020 · Cited by 358
Self-citationMaddox, L., & Schwartz, D. A. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103921 · Cited by 330
Tselepis, A. D., & John Chapman, M. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00045-4 · Cited by 314
Inflammatory Mediators of Cerebral Endothelium: A Role in Ischemic Brain Inflammation
Stanimirovic, D., & Satoh, K. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00248.x · Cited by 314
Self-citationPlatelet-activating Factor Acetylhydrolases
Stafforini, D. M., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17895 · Cited by 270
Self-citationBARNES, P. J. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.03721.x · Cited by 270
Dyslipidemia Associated with Atherosclerotic Disease Systemically Alters Dendritic Cell Mobilization
Angeli, V., Llodrá, J., Rong, J. X., Satoh, K., Ishii, S., Shimizu, T., Fisher, E. A., & Randolph, G. J. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.003 · Cited by 257
Self-citationInvestigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA 2 Inhibitor
Measom, N. D., Down, K. D., Hirst, D. J., Jamieson, C., Manas, E. S., Patel, V. K., & Somers, D. O. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00281 · Cited by 253
Lipoprotein‐associated phospholipase A2: The story continues
Huang, F., Wang, K., & Shen, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21597 · Cited by 212
“1, is organized in 12 exons and encodes 441 amino acids.(70,71) Numerous variations were identified within PLA2G7, and the corresponding alterations in physiology and body homeostasis have been illustrated to varying degrees.”
BackgroundGrallert, H., Dupuis, J., Bis, J. C., Dehghan, A., Barbalic, M., Baumert, J., Lu, C., Smith, N. L., Uitterlinden, A. G., Roberts, R., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr372 · Cited by 83
Mast-cell responses in the development of asthma
Bingham, C. O., & Austen, K. F. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90056-3 · Cited by 80
Metadata
- Authors
- Stafforini, D. M., Satoh, K., Atkinson, D. L., Tjoelker, L. W., Eberhardt, C., Yoshida, H., Imaizumi, T., Takamatsu, S., Zimmerman, G. A., McIntyre, T. M., Gray, P. W., & Prescott, S. M.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-15
- Volume
- 97
- Issue
- 12
- Pages
- 2784-2791
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2049007654
- Cited by
- 267
- References
- 30
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.